Two major clinical trials evaluating the potential of the weight-loss drug semaglutide to treat Alzheimer’s disease have ...

Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the ...

Alzheimer's patients have been dealt a blow after disappointing results from a major trial. Novo Nordisk has announced that ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a ...

Novo Nordisk said on Monday an older oral version of its semaglutide drug failed to meet its main ​goal in late-stage trials ...

Researchers have discovered that the heartbreaking moment when a person with Alzheimer’s no longer recognizes family may stem from the breakdown of perineuronal nets, protective structures that ...

One of the most devastating moments for family members of a patient with Alzheimer's is when their loved one forgets who they ...

Scientists hail ‘very exciting’ findings that explain why Alzheimer’s patients forget their loved ones, and say drugs are ...

We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

Almost all community-dwelling older adults with advanced dementia in Singapore had at least one potentially burdensome intervention in their last year of life, according to a November article ...